Prognostic value of test(s) for O6‐methylguanine–DNA methyltransferase (MGMT) promoter methylation for predicting overall survival in people with glioblastoma treated with temozolomide
There's more to see -- the rest of this topic is available only to subscribers.
Citation
"Prognostic Value of Test(s) for O6‐methylguanine–DNA Methyltransferase (MGMT) Promoter Methylation for Predicting Overall Survival in People With Glioblastoma Treated With Temozolomide." Cochrane Abstracts, Evidence Central, evidence.unboundmedicine.com/evidence/view/Cochrane/431926/2/images/repview. Accessed 18 May 2024.
Prognostic value of test(s) for O6‐methylguanine–DNA methyltransferase (MGMT) promoter methylation for predicting overall survival in people with glioblastoma treated with temozolomide. Cochrane Abstracts. https://evidence.unboundmedicine.com/evidence/view/Cochrane/431926/2/images/repview. Accessed May 18, 2024.
Prognostic value of test(s) for O6‐methylguanine–DNA methyltransferase (MGMT) promoter methylation for predicting overall survival in people with glioblastoma treated with temozolomide. In Cochrane Abstracts https://evidence.unboundmedicine.com/evidence/view/Cochrane/431926/2/images/repview
Prognostic Value of Test(s) for O6‐methylguanine–DNA Methyltransferase (MGMT) Promoter Methylation for Predicting Overall Survival in People With Glioblastoma Treated With Temozolomide [Internet]. In: Cochrane Abstracts. [cited 2024 May 18]. Available from: https://evidence.unboundmedicine.com/evidence/view/Cochrane/431926/2/images/repview.
* Article titles in AMA citation format should be in sentence-case
TY - ELEC
T1 - Prognostic value of test(s) for O6‐methylguanine–DNA methyltransferase (MGMT) promoter methylation for predicting overall survival in people with glioblastoma treated with temozolomide
ID - 431926
BT - Cochrane Abstracts
UR - https://evidence.unboundmedicine.com/evidence/view/Cochrane/431926/2/images/repview
DB - Evidence Central
DP - Unbound Medicine
ER -